Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial-Reference-Cited by-同舟云学术

Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial

Published:2017-09-23 Issue:2 Volume:92 Page:253-259
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Price Matthew J.¹^ORCID,Shlofmitz Richard A.²,Spriggs Douglas J.³,Haldis Thomas A.⁴,Myers Paul⁵,Popma Almonacid Alexandra⁶,Maehara Akiko⁷,Dauler Michelle⁸,Peng Yun⁸,Mehran Roxana⁹

Affiliation:

1. Department of Cardiovascular Diseases; Scripps Clinic; La Jolla California USA

2. Department of Cardiology; Saint Francis Hospital; Roslyn New York USA

3. Department of Interventional Cardiology; Morton Plant Hospital; Clearwater Florida USA

4. Department of Interventional Cardiology; Sanford Health; Fargo North Dakota USA

5. Department of Interventional Cardiology; Tristar Centennial Medical Center; Nashville Tennessee USA

6. Cardiovascular Imaging Core Laboratory; Beth Israel Deaconess Medical Center; Boston Massachusetts USA

7. Cardiovascular Research Foundation; New York USA

8. Coronary Clinical Department; Medtronic; Santa Rosa California USA

9. Department of Cardiology; Mount Sinai Medical Center; New York USA

Funder

Medtronic, Santa Rosa, California

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.27322/fullpdf

Reference12 articles.

1. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents;Serruys;N Engl J Med,2010

2. One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry;Neumann;EuroIntervention,2012

3. Three-year outcomes of percutaneous coronary intervention with next-generation zotarolimus-eluting stents for de novo coronary bifurcation lesions;Ferenc;J Invasive Cardiol,2014

4. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-lifepractice (COMPARE): a randomised trial;Kedhi;Lancet,2010

5. Alterations in wall shear stress predict sites of neointimal hyperplasia after stent implantation in rabbit iliac arteries;LaDisa;Am J Physiol Heart Circ Physiol,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Final 5‐year report of BIONYX comparing the thin‐composite wire‐strut zotarolimus‐eluting stent versus ultrathin‐strut sirolimus‐eluting stent;Catheterization and Cardiovascular Interventions;2024-05-07

2. Three-Year Outcomes After Bifurcation Stenting With Zotarolimus-Eluting Stents: Final Results From the RESOLUTE ONYX Postapproval Study;Journal of the Society for Cardiovascular Angiography & Interventions;2023-11

3. Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents;Journal of Clinical Medicine;2023-10-24

4. Design and Rationale of the BIOFLOW-DAPT Trial: a Prospective, Randomized, Multicenter Study to Assess the Safety of the Orsiro Mission Stent Compared to the Resolute Onyx Stent in Subjects at High Risk for Bleeding in Combination with 1-Month Dual Antiplatelet Therapy;Journal of Cardiovascular Translational Research;2023-06-01

5. A technology evaluation of the Onyx Frontier drug-eluting stent;Expert Opinion on Drug Delivery;2023-05-04